<?xml version="1.0" encoding="UTF-8"?>
<p id="p0360">Moreover, on May 19th a clinical trails (NCT04394182) on patients affected by COVID-19 has started. In this trial, an experimental group with a poor or no response to standard medical treatment and without invasive mechanical ventilation are planned to receive an ultra low-dose lung radiotherapy (0.8Â Gy single dose) in addiction with different drugs (including Piperacillin/tazobactam).</p>
